Social Phobia and Clonazepam
- 1 June 1990
- journal article
- research article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 35 (5) , 439-441
- https://doi.org/10.1177/070674379003500514
Abstract
Five patients meeting the DSM-III-R criteria for social phobia, without any other psychiatric diagnosis, were treated with clonazepam, a high potency benzodiazepine. All patients improved markedly within four weeks. By the end of the eighth week of treatment, a marked improvement of their symptoms was reported. The adverse effects were minimal at an average dose of 3 mg per day. The authors suggest that clonazepam is a safe and effective medication in the treatment of social phobia. Moreover, clonazepam is easier to use as compared to other drugs which are used (atenolol, phenelzine, alprazolam).Keywords
This publication has 12 references indexed in Scilit:
- A pilot study of treatment of social phobia with alprazolamAmerican Journal of Psychiatry, 1988
- Drug treatment of social phobiaJournal of Affective Disorders, 1987
- Clinical Presentation and Neuropharmacology of Restless Legs SyndromeClinical Neuropharmacology, 1987
- Clonazepam in the Treatment of Panic Disorder and AgoraphobiaJournal of Clinical Psychopharmacology, 1986
- The Epidemiology of AnxietyJournal of Nervous & Mental Disease, 1986
- Social PhobiaArchives of General Psychiatry, 1985
- Antipanic effect of clonazepamAmerican Journal of Psychiatry, 1984
- Social Phobia: A Comparative Clinical StudyThe British Journal of Psychiatry, 1983
- The Treatment of Social PhobiaJournal of Nervous & Mental Disease, 1981
- ClonazepamDrugs, 1976